Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

被引：0
|
作者：
Alison M. Pease
Luis A. Riba
Ryan A. Gruner
Nadine M. Tung
Ted A. James
机构：
[1] Harvard Medical School,Department of Surgery, Beth Israel Deaconess Medical Center
[2] Harvard Medical School,Department of Surgery/Linsey BreastCare Center, Beth Israel Deaconess Medical Center
[3] Harvard Medical School,Department of Medicine/Division of Hematology – Oncology, Beth Israel Deaconess Medical Center
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：366 / 371
页数：5
相关论文
共 50 条
  • [41] Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma
    Sahin, A.
    BREAST DISEASES, 2016, 27 (02): : 129 - 130
  • [42] Validation of Modified Magee Equation to Predict the Oncotype DX Recurrence Score
    Neely, Cameron
    Yang, Jing
    Bhattarai, Shristi
    Peng, Limin
    Krishnamurti, Uma
    Aneja, Ritu
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2016, 96 : 61A - 62A
  • [43] Routine Ancillary Studies Accurately Are Correlated with Oncotype DX Recurrence Score
    Owings, R.
    Gould, E.
    Renshaw, A.
    LABORATORY INVESTIGATION, 2014, 94 : 73A - 74A
  • [44] Routine Ancillary Studies Accurately Are Correlated with Oncotype DX Recurrence Score
    Owings, R.
    Gould, E.
    Renshaw, A.
    MODERN PATHOLOGY, 2014, 27 : 73A - 74A
  • [45] Applying new Magee equations for predicting the Oncotype Dx recurrence score
    Sughayer, Maher
    Alaaraj, Rolla
    Alsughayer, Ahmad
    BREAST CANCER, 2018, 25 (05) : 597 - 604
  • [46] Validation of Modified Magee Equation to Predict the Oncotype DX Recurrence Score
    Neely, Cameron
    Yang, Jing
    Bhattarai, Shristi
    Peng, Limin
    Krishnamurti, Uma
    Aneja, Ritu
    Li, Xiaoxian
    MODERN PATHOLOGY, 2016, 29 : 61A - 62A
  • [47] Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score
    Casasanta, Nicole
    Kipnis, Sarit T.
    Linville, Laura
    Lipinski, Shawn
    Knoedler, Alice
    Marino, Amy
    McHenry, Allision
    Biagi, Tara
    Stark, Elizabeth
    Amdur, Richard
    Denduluri, Neelima
    Rodriguez, Patricia
    Isaacs, Claudine
    Kaltman, Rebecca
    CLINICAL BREAST CANCER, 2020, 20 (02) : 125 - 130
  • [48] The value of algorithms predicting the Oncotype DX recurrence score should not be underestimated!
    Turner, Bradley
    Tang, Ping
    Hicks, David
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (01) : 249 - 250
  • [49] Prediction of oncotype DX® recurrence score using pathology generated equations
    Bhargava, R.
    Klein, M. E.
    Shuai, Y.
    Brufsky, A. M.
    Puhalla, S. L.
    Jankowitz, R.
    Dabbs, D. J.
    CANCER RESEARCH, 2012, 72
  • [50] Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score
    S Sahebjam
    R Aloyz
    D Pilavdzic
    M-L Brisson
    C Ferrario
    N Bouganim
    V Cohen
    W H Miller
    L C Panasci
    British Journal of Cancer, 2011, 105 : 1342 - 1345
12345